Physician

Hillary Lane Bownik, M.D

According to 2025 Medicare claims, Hillary Bownik, M.D (NPI: 1013147206) practices gastroenterology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is MID AMERICA GASTRO INTESTINAL CONSULTANTS P C (NPI: 1710091228; TIN: 431356738) and primary practice location at 64111-5936.

Bownik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 559 traditional Medicare patients, billed 61,872 HCPCS/CPT codes, and received $1,076,721 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,373 prescription claims across 479 beneficiaries totaling $3,534,126 in drug costs, led by Stelara (Ustekinumab). 2021 DME data shows 13 claims. Open Payments data shows 63 records totaling $14,252. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,304 to $1,076,721. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,018 to $3,534,126. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	35	38	$4,304
2016	118	374	$18,191
2017	192	3,888	$92,018
2018	284	17,823	$321,384
2019	347	36,084	$660,416
2020	347	56,409	$1,275,841
2021	553	61,473	$1,235,855
2022	539	55,343	$965,113
2023	560	64,639	$1,081,024
2024	559	61,872	$1,076,721

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	52	85	$4,018
2016	54	129	$41,600
2017	65	214	$61,381
2018	143	379	$142,293
2019	181	485	$139,804
2020	181	611	$244,751
2021	340	916	$614,536
2022	338	977	$1,254,574
2023	367	1,158	$3,016,634
2024	479	1,373	$3,534,126

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	13	$356
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	104	109	$198
45380	Biopsy of large bowel using a flexible endoscope	100	104	$103
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	107	107	$72
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	67	69	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	115	128	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	61	2,884	$1,888,477
Humira(Cf) Pen	Adalimumab	60	1,784	$606,111
Gattex	Teduglutide	12	360	$556,290
Creon	Lipase/Protease/Amylase	20	881	$92,890
Rinvoq	Upadacitinib	11	328	$74,951

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$13,384	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$868	Celgene Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hillary Lane Bownik, M.D?

Tedicare shows public-source Medicare data for Hillary Lane Bownik, M.D (NPI 1013147206), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hillary Lane Bownik, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hillary Lane Bownik, M.D?

Hillary Lane Bownik, M.D is linked to MID AMERICA GASTRO INTESTINAL CONSULTANTS P C (billing NPI 1710091228) in the available physician profile data.

Does Hillary Lane Bownik, M.D have Open Payments data?

Hillary Lane Bownik, M.D has 63 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.